Aclarion

Aclarion EBITDA per Employee

The EBITDA per Employee of Aclarion (ACON) as of Oct 16, 2026 is -1.01 M USD. In the previous year, EBITDA per Employee was -922,494.29 USD — a change of 9.21% (lower).

EBITDA per Employee

-1.01 MUSD

YoY

9.21%

Last updated:

EBITDA per Employee of Aclarion is 2025 -1.01 M USD. EBITDA per Employee of Aclarion was 2024 -922,494.29 USD. It decreases by 9.21% lower compared to the previous year.

The Aclarion EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
-573,466.14 USD
Jan 1, 2020
-639,883.71 USD
Jan 1, 2021
-639,115.71 USD
Jan 1, 2022
-794,793.86 USD
Jan 1, 2023
-614,751.14 USD
Jan 1, 2024
-922,494.29 USD
Jan 1, 2025
-1.01 M USD
The Aclarion EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-1.01 MUSD+9.21%
-922,494.29USD+50.06%
-614,751.14USD-22.65%
-794,793.86USD+24.36%
-639,115.71USD-0.12%
-639,883.71USD+11.58%
-573,466.14USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aclarion Stock analysis

What does Aclarion do? Aclarion Inc, trading under the ticker ACON, is a healthcare technology company based in Broomfield, Colorado, with a focus on medical diagnostics. The company specializes in Magnetic Resonance Spectroscopy (MRS) and has developed a proprietary biomarker designed to optimize clinical treatments for patients with chronic low back pain. Aclarion's technology processes raw MRS data using signal processing software and an expert system to generate clear metabolic biomarkers. These biomarkers help physicians distinguish between painful and nonpainful lumbar discs. The company utilizes augmented intelligence in a post-processing algorithm to analyze and quantify biomarker data, producing individualized ratio metrics for each lumbar disc based on a normative data set. Aclarion went public via an IPO on April 22, 2022. The company employs seven full-time staff members. Its website is aclarion.com. Aclarion operates within the Health Care sector and Industry, targeting the optimization of treatment strategies for chronic low back pain through advanced diagnostic tools. Aclarion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aclarion stock

EBITDA per Employee of Aclarion is -1.01 M USD in 2025.

EBITDA per Employee of Aclarion changed from -922,494.29 USD to -1.01 M USD, representing a 9.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Aclarion since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Aclarion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Aclarion

All Key Metrics — Aclarion